ARFH Community TB Project 2019-2020 Brief
ARFH is currently implementing the Community TB component of the GF- Funded Tuberculosis grant Nigeria in collaboration with the National Tuberculosis and Leprosy Control Programme (NTBLCP), the Principal Recipient of the grant and an institution mandated to coordinate TB and Leprosy control activities in all States in Nigeria in order to significantly reduce the public burden of the two diseases. This grant has continued this Jan, 2021 to end Dec, 2023.
The Global Fund Community Tuberculosis Grant Implementation
About the Project ARFH is currently implementing the Community TB component of the GF- Funded Tuberculosis grant Nigeria in collaboration with the National Tuberculosis and Leprosy Control Programme (NTBLCP), the Principal Recipient of the grant, and an institution mandated to coordinate TB and Leprosy control activities in all States in Nigeria in order to significantly […]
Step by step guide on how to use DMPA-SC/Self Injection
This video shows a step by step guide for women who have chosen to use subcutaneous DMPA-SC/Self Injection in the context of informed choice counseling. DMPA-SC/SI is a lower-dose, easy-to-use injectable contraceptive that is administered every three months. The product’s user-friendly design means that any trained person can administer it, including community health workers, pharmacists, and even women themselves.
ARFH’S Relentless Effort in Ensuring Uptake Of Family Planning Services in the Face Of COVID-19
Despite the novel COVID-19 pandemic that has disrupted health service delivery and caused backdrop for businesses in the past months, the RASuDiN Project continued to demonstrate the feasibility of expanding access to Family Planning (FP) method uptake, increasing self-care among women of reproductive age (WRA) and improving continuation rate of DMPA-SC/SI. ARFH RASuDiN project under […]
ARFH Clinic- ARFH Olikoye Ransome Kuti Medical Center Services and Achievements
At Olikoye Ransome Kuti Medical Centre (ORMC) of Association for Reproductive and family health, we offer a wide range of quality reproductive health services through an integrated approach in ensuring our clients access world class health services. These are Medical, surgical, Obstetric and Gynecological services including antenatal and postnatal care, family planning, endocrinology, Neurology, Urology, […]
ARFH-ICHSSA 2 Project-Surviving Malnutrition During COVID-19 Crisis: Roqueeba’s Story
The first 1000 days of a child’s life offer a unique window of opportunity for preventing malnutrition and its consequences. Sadly, in Nigeria, not every baby gets to enjoy or survive this period of their life. According to UNICEF, Nigeria has the second highest burden of stunted children in the world with an estimated 2 […]
ARFH-Global Fund HIV Sexual Network Testing: A Game-Changer in Positive Case Findings
ARFH is implementing the community HIV Testing Services across 11 States in Nigeria with support from the Global Fund (GF) to fight AIDS, TB, and Malaria, through fhi360. HIV positivity yield across the 11 project implementing states is at about 1.5%. Hence, in optimizing HIV investment for impact, ARFH adopted the Sexual Network Testing (SNT) […]
RASuDiN Policy Briefs: Empowering Women for a Healthier Future in Anambra, Enugu, Delta, Oyo, Lagos, Kwara, Niger, Plateau, Ogun and Rivers States
The Resilient & Accelerated Scale-up of DMPA-SC/Self-injection in Nigeria (RASuDiN) project aims to increase use, acceptance, availability, and accessibility of DMPA-SC, expanding the family planning method mix for women of reproductive age in Nigeria. The project is led by Association for Reproductive and Family Health (ARFH) in partnership with the Centre for Communication and Social […]
Report: Investing For Impact Against TB & HIV NGA-T-ARFH 2015-2018
ARFH with the support of The Global Fund implemented the “Investing for Impact Against TB & HIV” project across 22 priority states in Nigeria between 2015-2018. The goal of the project was to provide Nigerians with universal access to high quality, patient-centred prevention, diagnosis, and treatment services for TB, TB/HIV, and drug-resistant TB by 2020. […]